Showing results (1501-1510 of 1,886) with videos related to
Sort By:
Pageof 189
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancerBenjamin J Moeller, Vishal Rana, Blake A Cannon, et al.International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
Prospective imaging assessment of mortality risk after head-and-neck radiotherapyBenjamin J Moeller, Vishal Rana, Blake A Cannon, et al.Lancet (London, England)|May 28, 2026
Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trialsStephen L Hauser, Gavin Giovannoni, Xavier Montalban, et al.Cell Stem Cell|December 26, 2017
Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AMLDelfim Duarte, Edwin D Hawkins, Olufolake Akinduro, et al.Brain, Behavior, and Immunity|April 24, 2026
The role of lymphocytic CD5 in the effects of ethanol on mesolimbic circuitry and ethanol consumption behaviorA J Payne, J D Obray, B M Williams, et al.The Lancet. Oncology|April 5, 2015
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trialAlexander M M Eggermont, Vanna Chiarion-Sileni, Jean-Jacques Grob, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2017
Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled AnalysisSandra P D'Angelo, James Larkin, Jeffrey A Sosman, et al.Plos One|November 14, 2014
Clonal architectures and driver mutations in metastatic melanomasLi Ding, Minjung Kim, Krishna L Kanchi, et al.European Journal of Cancer (Oxford, England : 1990)|December 22, 2020
Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neckMoran Amit, Chuan Liu, Frederico-Omar Netto Gleber, et al.Cancer|November 21, 2015
Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapyJian Ji Pan, Wai Tong Ng, Jing Feng Zong, et al.Pageof 189